Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 3/20 | 0.67 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.61 |
| ▸ | CYP2C8 | P10632 | 3/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.61 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.61 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.56 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | HTR1A | P08908 | 3/20 | 0.56 |
| ▸ | LTA4H | P09960 | 2/20 | 0.56 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.56 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6583008 | 0.90 | ALOX5 (0.62) | ALOX5OR51E2CYP1A2CYP3A4CYP2C8 | |
| SCHEMBL4007566 | 0.89 | ALOX5 (0.77) | ALOX5OR51E2CYP1A2CYP3A4CYP2C8 | |
| Dihydroferulic Acid Propyl Ester SCHEMBL22353585 | 0.89 | ALOX5 (0.63) | ALOX5OR51E2CYP1A2CYP3A4CYP2C8 | |
| SCHEMBL1550337 | 0.88 | CYP4F2 (0.56) | ALOX5OR51E2CYP1A2CYP3A4CYP2C8 | |
| SCHEMBL491225 | 0.88 | CYP19A1 (0.60) | ALOX5OR51E2CYP1A2CYP3A4CYP2C8 | |
| SCHEMBL491276 | 0.88 | CYP4F2 (0.59) | CYP1A2CYP3A4CYP4F2CYP4A11LMNA | |
| SCHEMBL16661623 | 0.87 | ALOX5 (0.65) | ALOX5OR51E2CYP1A2CYP3A4CYP2C8 | |
| SCHEMBL16661624 | 0.87 | ALOX5 (0.65) | ALOX5OR51E2CYP1A2CYP3A4CYP2C8 | |
| SCHEMBL8912630 | 0.87 | CYP4F2 (0.58) | ALOX5OR51E2CYP1A2CYP3A4CYP2C8 | |
| Dihydroferulic Acid Methyl Ester SCHEMBL490876 | 0.86 | ALOX5 (0.77) | ALOX5OR51E2CYP1A2CYP3A4CYP2C8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350133-A | Method for preparing 4-propyl eugenol by catalyzing lignin to hydrogenolysis through cobalt-nitrogen co-doped porous carbon | 华南理工大学 | 2025-01-24 | — | — | CN | claimed |
| CN-119350133-A | Method for preparing 4-propyl eugenol by catalyzing lignin to hydrogenolysis through cobalt-nitrogen co-doped porous carbon | 华南理工大学 | 2025-01-24 | — | — | CN | disclosed |
| CN-109310796-B | Absorbent article comprising cyclodextrin complex | 宝洁公司 | 2021-10-15 | — | — | CN | disclosed |
| EP-2925755-B1 | NEUROPROTECTIVE AGENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | UNIV WAYNE STATE (US) | 2021-09-08 | — | — | EP | disclosed |
| CN-109219453-B | Absorbent article comprising cyclodextrin complex | 宝洁公司 | 2021-07-06 | — | — | CN | disclosed |
| US-10874669-B2 | Neuroprotective agents for treatment of neurodegenerative diseases | WAYNE STATE UNIVERSITY (US) | 2020-12-29 | — | — | US | disclosed |
| EP-2595952-B1 | AGONISTS OF GPR40 | CONNEXIOS LIFE SCIENCES PVT LTD (IN) | 2020-11-18 | — | — | EP | disclosed |
| US-20200317593-A1 | LIGNIN CONVERSION TO PHENOLIC MOLECULES USING TRANSITION METAL CATALYSTS | SPERO RENEWABLES, LLC | 2020-10-08 | — | — | US | disclosed |
| EP-3717496-A1 | LIGNIN CONVERSION TO PHENOLIC MOLECULES USING TRANSITION METAL CATALYSTS | Spero Renewables, LLC (US) | 2020-10-07 | — | — | EP | disclosed |
| CN-106999406-B | Anhydrous cosmetic composition for topical application | 宝洁公司 | 2020-09-08 | — | — | CN | disclosed |
| US-5962695-A | ANTICOAGULANT | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1999-10-05 | — | — | US | disclosed |
| US-5866577-A | AN ANTICOAGULANT AGENT | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1999-02-02 | — | — | US | disclosed |
| WO-1998029407-A2 | N-(PYRIDINYLAMINO)ISOINDOLINES FOR TREATING ALZHEIMER'S AND DEPRESSION | HOECHST MARION ROUSSEL, INC. (US) | 1998-07-09 | — | — | WO | disclosed |
| CN-1168886-A | Process for production of amidinobenzofuran and amidionbenzothiophen derivatives and salt thereof | DAIICHI SEIYAKU CO (JP) | 1997-12-31 | — | — | CN | disclosed |
| CN-1168885-A | Process for prodn. of amidinoindole derivatives and salts thereof | DAIICHI SEIYAKU CO (JP) | 1997-12-31 | — | — | CN | disclosed |
| US-5620991-A | ANTICOAGULANTS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1997-04-15 | — | — | US | disclosed |
| US-5576343-A | ANTICOAGULANTS; BLOOD-COAGULATION FACTOR X INHIBITORS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1996-11-19 | — | — | US | disclosed |
| EP-0540051-B1 | Aromatic amidine derivatives and salts thereof | DAIICHI SEIYAKU CO (JP) | 1996-04-03 | — | — | EP | disclosed |
| CN-1072677-A | Aromatic amidine derivative and salt thereof | DAIICHI SEIYAKU CO (JP) | 1993-06-02 | — | — | CN | disclosed |
| EP-0540051-A1 | Aromatic amidine derivatives and salts thereof | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1993-05-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10874669-B2 | Neuroprotective agents for treatment of neurodegenerative diseases | SMN1; SMN2, PARK7, SNCA | ALOX5 3375/4885OR51E2 3221/4885CYP1A2 3835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.